Vaccine maker Novavax says its COVID-19 shot is highly effective against the coronavirus and also protects against variants.
The biotech company based out of Maryland announced their data from a large, late-stage study conducted in the U.S. and Mexico.
Novavax says the study found their vaccine was 90% effective.
They plan to file for emergency use authorization in the U.S. and other countries by September.
